Thawani, Akanksha http://orcid.org/0000-0003-4168-128X
Ariza, Alfredo Jose Florez http://orcid.org/0000-0003-2429-4659
Nogales, Eva http://orcid.org/0000-0001-9816-3681
Collins, Kathleen
Article History
Received: 14 April 2023
Accepted: 4 December 2023
First Online: 14 December 2023
Competing interests
: K.C. is an equity holder and scientific advisor for Addition Therapeutics, which uses a different retrotransposon protein for gene therapy technology. UC Berkeley has filed a provisional patent application on L1 ORF2p RNP engineering with all of the authors listed as inventors.